Yuko Sakai‐Tagawa

机构：Tokyo University of Science, The University of Tokyo · ORCID：0000-0002-7261-4648

发表论文 88 篇 · 总被引 10727 次 · h-index 41

代表论文

• Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants (2022 · New England Journal of Medicine · 被引 326)
• Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB (2022 · New England Journal of Medicine · 被引 289)
• Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB (2022 · The Lancet Infectious Diseases · 被引 198)
• Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate (2023 · The Lancet Infectious Diseases · 被引 112)
• Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents (2022 · Nature · 被引 111)
• A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases (2022 · Nature Communications · 被引 65)